The percentage of change of the FEVI as a function of the following administration of fewtemi solution Each horizontal pmel represents a series of studies on a single patient The vertical pamls represent a ttuee-hm study following a number of w M s of fewterol solution. tbe number indicated by the large numeral at the top. The mll number over each plat indicates the innease in milliliters of the FEV, at madmum response (note the modest absolute improvement frequently sssaciated with dramatic percent increase). The small star at the beginning of each pawl refers to the FEV, prior to fenoteml using the vert;cal scale as percentage of predicted rather than as percentage of change. subject in a study, then one must test the subject at the time of his maximum response in order not to miss an adequate response. Tbis is, of course, impossible since it requires continuous testing. I f continuous testing is not done the maximum response could occur between tests and would. therefore, be missed. The 
subject in a study, then one must test the subject at the time of his maximum response in order not to miss an adequate response. Tbis is, of course, impossible since it requires continuous testing. I f continuous testing is not done the maximum response could occur between tests and would. therefore, be missed. The minutes after individual coded treatments. A parallelline bioassay was used to determine the relative po. tencies of the two drugs for their respiratory and pulse rate functions, defining relative potency as the ratio of the dose of isoproterenol to a given dose of fenoterol producing an equal response; a quantitative selectivity ratio was computed from these data. A second index was determined by calculating the ratio of percentage changes in ventilatory function to percentage changes in pulse rate at all test points for the four doses of the two aerosols.
Rapults: Both aerosols produced a signi6cant bronchodilatation. At all levels of inhalation dosage, fenoterol induced a shorter and less marked cardioacceleration than isoproterenol (Fig 1) . One inhalation of fenoterol was as effective as 1.16 inhalations of isoproterenol in improving the FEV,,,, whereas more than three inhalations of the former were needed to speed the pulse as much as one whiff of isoproterenol; these data furnish a quantitative selectivity ratio for fenoterol of 3.86. Similar treatment of the MEFR and pulse rate figures yielded a : of fen&ml and iraproterenol on the mean puke selectivity ratio for bronchodilatation versus tachycardia for these variables of 3.70. When the same data are tabulated as percentage change in ventilatory function over percentage change in pulse rate, the overall results emphasize the superiority of fenoteml in standard clinical d m as a selective bronchodilator. Both approaches suggest that inspection of the FEV,,, MEFR and PEFR indices in relation to pulse rate values furnishes a ~ractical method of assessing the beta, properties of bronchodilators.
Neither aerosol changed the blood pressure sign&-cantly. CNS and cardiovascular manifestations, the principal side effects, were more frequent after isoproterenol inhalations. Digestive, musculoskeletal and central activity appeared only with 8 inhalations (1.6 mg) of fen* terol.
The ventilatory advantages of fenoterol, the minimal undesirable effects when given in one or two inhalations, and the difference &em bronchodilator and tachycardiac potencies indicated by quantitative selectivity ratios computed using simple lung function tests, indicate that this agent surpasses isoproterenol in the beta, selectivity of its actirm. 
